Stockscreener 앱 받기
5.92
14.57%
-1.01
시간 외 거래:
5.61
-0.31
-5.24%
전일 마감가:
$6.93
열려 있는:
$6.4
하루 거래량:
4.68M
Relative Volume:
4.24
시가총액:
$7.14M
수익:
-
순이익/손실:
-
주가수익비율:
-
EPS:
-
순현금흐름:
-
1주 성능:
-21.28%
1개월 성능:
-23.42%
6개월 성능:
-98.98%
1년 성능:
-99.87%
1일 변동 폭
$5.405
$6.6999
1주일 범위
$5.405
$7.602
52주 변동 폭
$5.405
$17,908.00
Cero Therapeutics Holdings Inc Stock (CERO) Company Profile
명칭
Cero Therapeutics Holdings Inc
전화
650-407-2376
주소
201 HASKINS WAY, SOUTH SAN FRANCISCO
CERO을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
CERO
Cero Therapeutics Holdings Inc
|
5.92 | 8.35M | 0 | 0 | 0 | 0.00 |
|
VRTX
Vertex Pharmaceuticals Inc
|
396.12 | 101.77B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
573.38 | 60.12B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
452.00 | 59.45B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
750.78 | 44.90B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
341.80 | 35.07B | 3.81B | -644.79M | -669.77M | -6.24 |
Cero Therapeutics Holdings Inc Stock (CERO) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-06-23 | 업그레이드 | D. Boral Capital | Hold → Buy |
Cero Therapeutics Holdings Inc 주식(CERO)의 최신 뉴스
Is CERo Therapeutics Holdings Inc. being accumulated by smart moneyWeekly Profit Analysis & Weekly Consistent Profit Watchlists - خودرو بانک
Is CERo Therapeutics Holdings Inc. stock a good pick for beginnersMarket Growth Summary & High Accuracy Swing Entry Alerts - خودرو بانک
Published on: 2025-09-05 23:15:37 - خودرو بانک
What are CERo Therapeutics Holdings Inc. Equity Warrant’s growth leversJuly 2025 Reactions & Weekly High Potential Alerts - خودرو بانک
What’s CERo Therapeutics Holdings Inc.’s historical returnWeekly Profit Summary & Entry Point Confirmation Alerts - خودرو بانک
Published on: 2025-09-06 00:07:46 - خودرو بانک
Is CERo Therapeutics Holdings Inc. stock overvalued or fairly pricedEarnings Growth Report & Fast Entry Momentum Alerts - خودرو بانک
How to manage a losing position in CERo Therapeutics Holdings Inc.July 2025 Action & Long-Term Growth Stock Strategies - Newser
Historical volatility pattern of CERo Therapeutics Holdings Inc. visualized2025 Institutional Moves & Growth Focused Entry Point Reports - Newser
Will CERo Therapeutics Holdings Inc. bounce back from current support2025 Technical Patterns & Safe Entry Momentum Stock Tips - Newser
How to track smart money flows in CERo Therapeutics Holdings Inc. Equity Warrant2025 Support & Resistance & Momentum Based Trading Signals - Newser
Will CERo Therapeutics Holdings Inc. Equity Warrant outperform its industry peers2025 Technical Overview & Comprehensive Market Scan Insights - خودرو بانک
Published on: 2025-09-05 13:18:23 - Newser
CERo Therapeutics Gets Fast Track Designation For Experimental Cancer Drug, But Stock Tumbles – Here’s What Happened - Stocktwits
Is CERo Therapeutics Holdings Inc.’s growth already priced inMarket Growth Summary & Weekly Watchlist of Top Performers - خودرو بانک
CERo Therapeutics’ CER-1236: A High-Conviction Biotech Play with Accelerated Regulatory Pathways and Transformative AML Potential - AInvest
Risk adjusted return profile for CERo Therapeutics Holdings Inc. Equity Warrant analyzed2025 Earnings Impact & Verified Swing Trading Watchlists - Newser
Cero Therapeutics receives FDA fast track designation for CER-1236 in acute myeloid leukemia (AML) - MarketScreener
Is CERo Therapeutics Holdings Inc. undervalued by DCF analysis2025 Retail Activity & Daily Profit Maximizing Trade Tips - خودرو بانک
CERo Therapeutics Holdings Inc. recovery potential after sell off2025 Investor Takeaways & High Accuracy Swing Entry Alerts - Newser
CERo Therapeutics Gains Fast Track for AML Drug - TipRanks
CERo Therapeutics Says FDA Grants Fast Track Designation to Potential Leukemia Treatment - MarketScreener
FDA grants fast track designation to CERo’s leukemia therapy - Investing.com
CERo Therapeutics Receives FDA Fast Track Designation for CER-1236 in Acute Myeloid Leukemia (AML) - GlobeNewswire
FDA Fast Track Designation: CERo's Novel Cancer Immunotherapy CER-1236 Advances Against Deadly AML - Stock Titan
Volatility clustering patterns for CERo Therapeutics Holdings Inc. Equity WarrantJuly 2025 Big Picture & Community Consensus Trade Signals - Newser
Forecasting CERo Therapeutics Holdings Inc. price range with options dataLong Setup & Real-Time Buy Signal Notifications - Newser
How to use a screener to detect CERo Therapeutics Holdings Inc. Equity Warrant breakoutsNew Guidance & Free Safe Entry Trade Signal Reports - Newser
Custom strategy builders for tracking CERo Therapeutics Holdings Inc. Equity WarrantMarket Sentiment Report & Daily Growth Stock Tips - Newser
Real time pattern detection on CERo Therapeutics Holdings Inc. stock - Newser
CERo Therapeutics Holdings Inc. stock trend forecastWeekly Investment Recap & Weekly Watchlist of Top Performers - Newser
Applying big data sentiment scoring on CERo Therapeutics Holdings Inc. Equity WarrantMarket Trend Summary & Verified Entry Point Detection - Newser
Can momentum traders help lift CERo Therapeutics Holdings Inc.Trade Risk Report & Daily Profit Maximizing Tips - Newser
How to integrate CERo Therapeutics Holdings Inc. Equity Warrant into portfolio analysis toolsMarket Movers & Safe Entry Point Alerts - Newser
How cyclical is CERo Therapeutics Holdings Inc.’s revenue streamLong Setup & AI Forecasted Entry and Exit Points - خودرو بانک
CERo Therapeutics Faces Nasdaq Delisting Risk - TipRanks
Using data tools to time your CERo Therapeutics Holdings Inc. Equity Warrant exitJuly 2025 Sentiment & Daily Volume Surge Trade Alerts - Newser
Does CERo Therapeutics Holdings Inc. meet Warren Buffett’s criteriaAnalyst Upgrade & Accurate Intraday Trading Signals - خودرو بانک
CERo Therapeutics Holdings Inc. Equity Warrant stock prediction for this weekRate Cut & Low Risk Growth Stock Ideas - Newser
Real time scanner hits for CERo Therapeutics Holdings Inc. explainedQuarterly Portfolio Summary & Weekly Setup with High ROI Potential - Newser
Applying Wyckoff theory to CERo Therapeutics Holdings Inc. stockM&A Rumor & Verified Swing Trading Watchlists - Newser
What is CERo Therapeutics Holdings Inc. Equity Warrant s debt to equity ratioMarket Risk Analysis & Consistent Profit Focused Trading Strategies - خودرو بانک
Order flow analysis tools used on CERo Therapeutics Holdings Inc.2025 Momentum Check & Technical Pattern Recognition Alerts - Newser
What’s the analyst consensus on CERo Therapeutics Holdings Inc. Equity WarrantVolume Spike & Free Safe Entry Trade Signal Reports - خودرو بانک
Is CERo Therapeutics Holdings Inc. stock a value trapWeekly Loss Report & Verified Trade Idea Suggestions - khodrobank.com
Will CERo Therapeutics Holdings Inc. Equity Warrant price bounce be sustainable2025 Earnings Impact & Reliable Breakout Stock Forecasts - Newser
Published on: 2025-09-03 06:13:25 - Newser
Applying sector rotation models to CERo Therapeutics Holdings Inc. Equity Warrant2025 Buyback Activity & Expert Verified Stock Movement Alerts - Newser
What indicators show strength in CERo Therapeutics Holdings Inc.2025 Buyback Activity & Weekly Stock Breakout Alerts - Newser
Is CERo Therapeutics Holdings Inc. impacted by rising ratesCPI Data & Safe Swing Trade Setup Alerts - خودرو بانک
Using RSI to spot recovery in CERo Therapeutics Holdings Inc.July 2025 Institutional & Long-Term Investment Growth Plans - Newser
Cero Therapeutics Holdings Inc (CERO) 재무 분석
Cero Therapeutics Holdings Inc (CERO)에 대한 금융 데이터가 없습니다. 더 많은 정보를 위해 다른 주식을 확인해보세요.
매출
순이익
현금흐름
주당 순 이익
1.40%
자본화:
|
볼륨(24시간):